125 related articles for article (PubMed ID: 29581785)
21. Methylenetetrahydrofolate reductase C677T polymorphism and the risk of unexplained recurrent pregnancy loss: a meta-analysis.
Ren A; Wang J
Fertil Steril; 2006 Dec; 86(6):1716-22. PubMed ID: 17074326
[TBL] [Abstract][Full Text] [Related]
22. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
[TBL] [Abstract][Full Text] [Related]
23. [Polymorphism of methylenetetrahydrofolate reductase and sensitivity of stomach cancer to fluoropyrimidine-based chemotherapy].
Gao CM; Lu JW; Toshiro T; Wu JZ; Cao HX; Chen HQ; Feng JF; Kazuo T
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Dec; 25(12):1054-8. PubMed ID: 15769364
[TBL] [Abstract][Full Text] [Related]
24. Folate Pathway Gene Methylenetetrahydrofolate Reductase C677T Polymorphism and Alzheimer Disease Risk in Asian Population.
Rai V
Indian J Clin Biochem; 2016 Jul; 31(3):245-52. PubMed ID: 27382194
[TBL] [Abstract][Full Text] [Related]
25. Methylenetetrahydrofolate reductase (
Rai V; Kumar P
AIMS Neurosci; 2021; 8(2):212-225. PubMed ID: 33709025
[TBL] [Abstract][Full Text] [Related]
26. Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to epilepsy.
Rai V; Kumar P
Neurol Sci; 2018 Dec; 39(12):2033-2041. PubMed ID: 30267335
[TBL] [Abstract][Full Text] [Related]
27. Relevance of methylenetetrahydrofolate reductase gene variants C677T and A1298C with response to fluoropyrimidine-based chemotherapy in colorectal cancer: a systematic review and meta-analysis.
Zhong L; He X; Zhang Y; Chuan JL; Chen M; Zhu SM; Peng Q
Oncotarget; 2018 Jul; 9(58):31291-31301. PubMed ID: 30131855
[TBL] [Abstract][Full Text] [Related]
28. Association between MTHFR C677T Polymorphism and Risk of Prostate Cancer: Evidence from 22 Studies with 10,832 Cases and 11,993 Controls.
Abedinzadeh M; Zare-Shehneh M; Neamatzadeh H; Abedinzadeh M; Karami H
Asian Pac J Cancer Prev; 2015; 16(11):4525-30. PubMed ID: 26107198
[TBL] [Abstract][Full Text] [Related]
29. Effects of MTHFR C677T and A1298C Polymorphisms on Migraine Susceptibility: A Meta-Analysis of 26 Studies.
Liu L; Yu Y; He J; Guo L; Li H; Teng J
Headache; 2019 Jun; 59(6):891-905. PubMed ID: 31045246
[TBL] [Abstract][Full Text] [Related]
30. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
Qi X; Ma X; Yang X; Fan L; Zhang Y; Zhang F; Chen L; Zhou Y; Jiang J
Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343
[TBL] [Abstract][Full Text] [Related]
31. The association between MTHFR gene polymorphisms (C677T, A1298C) and oral squamous cell carcinoma: A systematic review and meta-analysis.
Ge W; Jiao Y; Chang L
PLoS One; 2018; 13(8):e0202959. PubMed ID: 30142181
[TBL] [Abstract][Full Text] [Related]
32. Risk association of meningiomas with MTHFR C677T and GSTs polymorphisms: a meta-analysis.
Ding H; Liu W; Yu X; Wang L; Shao L; Yi W
Int J Clin Exp Med; 2014; 7(11):3904-14. PubMed ID: 25550898
[TBL] [Abstract][Full Text] [Related]
33. Methylenetetrahydrofolate reductase 677TT genotype may be associated with an increased lung cancer risk in North China: an updated meta-analysis.
Liu NB; Li J; Qi JF; Zhang ZZ; Wu X; Zhang JH
Med Sci Monit; 2014 Dec; 20():2817-23. PubMed ID: 25544260
[TBL] [Abstract][Full Text] [Related]
34. MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis.
Ding XP; Feng L; Ma L
Asian Pac J Cancer Prev; 2012; 13(8):3937-42. PubMed ID: 23098496
[TBL] [Abstract][Full Text] [Related]
35. Relevance of
Zhong L; Fu Q; Zhou S; Chen L; Peng Q
BMJ Open; 2018 May; 8(5):e020767. PubMed ID: 29804062
[TBL] [Abstract][Full Text] [Related]
36. Systematic review and meta-analysis of the associations between maternal methylenetetrahydrofolate reductase polymorphisms and preterm delivery.
Fang Q; Jiang Y; Liu Z; Zhang Z; Zhang T
J Obstet Gynaecol Res; 2018 Apr; 44(4):663-672. PubMed ID: 29315997
[TBL] [Abstract][Full Text] [Related]
37. The association of MTHFR C677T variant with increased risk of ischemic stroke in the elderly population: a meta-analysis of observational studies.
Chang G; Kuai Z; Wang J; Wu J; Xu K; Yuan Y; Hu Y
BMC Geriatr; 2019 Nov; 19(1):331. PubMed ID: 31775641
[TBL] [Abstract][Full Text] [Related]
38. Methylenetetrahydrofolate reductase C677T polymorphism and cervical cancer risk: a meta-analysis.
Guo LN
Asian Pac J Cancer Prev; 2012; 13(5):2193-7. PubMed ID: 22901193
[TBL] [Abstract][Full Text] [Related]
39. Association between MTHFR C677T polymorphism and primary open-angle glaucoma: a meta-analysis.
Huo Y; Zou H; Lang M; Ji SX; Yin XL; Zheng Z; Liu W; Chen CL; Yuan RD; Ye J
Gene; 2013 Jan; 512(2):179-84. PubMed ID: 23123730
[TBL] [Abstract][Full Text] [Related]
40. Association of MTHFR C677T and A1298C Polymorphisms with Glaucoma Risk: a Systematic Review Meta-Analysis based 42 Case-Control Studies.
Gohari M; Mirjalili SA; Akbarian-Bafghi MJ; Jarahzadeh MH; Zare-Shehneh M; Neamatzadeh H
Rom J Ophthalmol; 2019; 63(2):107-118. PubMed ID: 31334388
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
